Tg Therapeutics, Inc.
TGTX
Revenue
120.86M
▲12.67M▲11.71%
3 Months ChangeAssets
656.69M
▲79.00M▲13.67%
3 Months ChangeLiabilities
419.40M
▲64.07M▲18.03%
3 Months ChangeFree Cash Flow
-28.74M
▼-20.53M▼-250.19%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-09
Form 10-Q
ID: 0001437749-24-025853
2024-08-06
Form 8-K
ID: 0001437749-24-024718
2024-06-17
Form 8-K
ID: 0001437749-24-020510
2024-05-06
Form 10-Q
ID: 0001437749-24-014849
2024-05-01
Form 8-K
ID: 0001437749-24-014062
2024-02-28
Form 8-K
ID: 0001437749-24-005802
2024-01-10
Form 8-K
ID: 0001437749-24-001061
2023-11-06
Form 10-Q
ID: 0001437749-23-030412
2023-11-01
Form 8-K
ID: 0001437749-23-029660
2023-08-04
Form 10-Q
ID: 0001558370-23-013429